5 Best Medical Stocks to Buy Under $30

Page 5 of 5

1. Pfizer Inc. (NYSE:PFE)

Pfizer Inc. (NYSE:PFE) is one of the best medical stocks to buy under $30. On April 20, Pfizer Inc. (NYSE:PFE) announced, together with Astellas Pharma Inc., that the US Food and Drug Administration has accepted a supplemental Biologics License Application (sBLA) for Priority Review.

The application is for the use of PADCEV (enfortumab vedotin-ejfv) in combination with the PD-1 inhibitor Keytruda (pembrolizumab), or Keytruda QLEX (pembrolizumab and berahyaluronidase alfa-pmph), as a perioperative treatment, given before and after surgery, for patients with muscle-invasive bladder cancer (MIBC).

This regimen was already approved by the FDA in November 2025 for patients with MIBC who are not eligible for cisplatin. The new application aims to expand the indication to patients with MIBC, regardless of whether they are eligible for cisplatin or not.

According to the report by Pfizer Inc. (NYSE:PFE), the FDA grants Priority Review to medicines that may offer major improvements in treatment or address conditions where there are limited therapy options. Under the Prescription Drug User Fee Act (PDUFA), a target action date of August 17, 2026, has been set by the FDA.

Pfizer Inc. (NYSE:PFE) is a leading pharmaceutical company that focuses on the discovery, development, and manufacture of healthcare products, medicines, and vaccines.

While we acknowledge the potential of PFE to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than PFE and that has 100x upside potential, check out our report about the cheapest AI stock.

READ NEXT: 10 Best Fintech Stocks to Invest In According to Billionaires and 10 Unrivaled Stocks of the Next 5 Years.

Disclosure: None.

Page 5 of 5